The global Pertussis Vaccine market was valued at US$ 5043.5 million in 2020 and is expected to reach US$ 6377.3 million by the end of 2027, growing at a CAGR of 3.5% during 2021-2027.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
Global Pertussis Vaccine Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Pertussis Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Find more details at: https://www.themarketreports.com/report/global-pertussis-vaccine-market-outlook
Segment by Type
- Whole-cell Vaccines
- Acellular Vaccines
Segment by Application
- 12 Months Below
- 12 Months Above
Table of Content:
1 Pertussis Vaccine Market Overview
2 Pertussis Vaccine Market Competition by Manufacturers
3 Pertussis Vaccine Retrospective Market Scenario by Region
4 Global Pertussis Vaccine Historic Market Analysis by Type
5 Global Pertussis Vaccine Historic Market Analysis by Application
6 Key Companies Profiled
7 Pertussis Vaccine Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Pertussis Vaccine Market Dynamics
10 Global Pertussis Vaccine Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta